MKI67 and neoplasm: Since apoptosis was similar in the HCI-12 PDX, despite differences in tumor volumes, we expected that changes in Ki67 would be observed in response to paclitaxel or sabizabulin treatment; however, no significant changes in Ki67 staining of tumor sections were observed among cohorts.